0.598

1.06% +0.0063

After Hours: .62 0.022 +3.68%

Cardio Diagnostics Holdings Inc (CDIO)

Overview News Price History Financials Discussions Forecast

Cardio Diagnostics Holdings Inc stock is currently priced at $0.598, with a 24-hour trading volume of 131.97K. It has seen a +1.06% increased in the last 24 hours and a -26.49% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.5974 pivot point. If it approaches the $0.6143 resistance level, significant changes may occur.

Previous Close:

$0.5917

Open:

$0.5917

24h Volume:

131.97K

Market Cap:

$13.57M

Revenue:

Net Income/Loss:

$-9.37M

P/E Ratio:

-0.8382

EPS:

-0.7134

Net Cash Flow:

$-7.34M

1W Performance:

-11.72%

1M Performance:

-26.49%

6M Performance:

-62.86%

1Y Performance:

-56.35%

1D Range:

$0.5703

$0.61

52W Range:

$0.171

$3.56

Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile

Name

Cardio Diagnostics Holdings Inc

Sector

Healthcare (1204)

Industry

Biotechnology (696)

Phone

855 226 9991

Address

400 North Abderdeen Street, Suite 900, Chicago

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CDIO's Discussions on Twitter

Cardio Diagnostics Holdings Inc Stock (CDIO) Latest News

Positron Corporation Joins Cardiac PET Industry Coalition (CPIC) - StockTitan

StockTitan

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality - Yahoo Finance

Yahoo Finance

DoubleDown Interactive (NASDAQ:DDI) Now Covered by Analysts at B. Riley - Defense World

Defense World

Benchmark ups Cardio Diagnostics shares target, sees market potential - Investing.com

Investing.com

Benchmark ups Cardio Diagnostics shares target, sees market potential By Investing.com - Investing.com

Investing.com

Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™ - br.ADVFN.com

br.ADVFN.com

Cardio Diagnostics Holdings Inc Stock (CDIO) Financials Data

Cardio Diagnostics Holdings Inc (CDIO) Net Income 2024

CDIO net income (TTM) was -$9.37 million for the quarter ending September 30, 2023, a -293.79% decrease year-over-year.

Cardio Diagnostics Holdings Inc (CDIO) Cash Flow 2024

CDIO recorded a free cash flow (TTM) of -$7.34 million for the quarter ending September 30, 2023, a -246.04% decrease year-over-year.

Cardio Diagnostics Holdings Inc (CDIO) Earnings per Share 2024

CDIO earnings per share (TTM) was -$0.9099 for the quarter ending September 30, 2023, a -263.96% decline year-over-year.

Cardio Diagnostics Holdings, Inc., a biotechnology company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks. The company was founded in 2017 and is headquartered in Chicago, Illinois.